Altshuler Shaham’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,250
Closed -$625 373
2025
Q1
$625 Sell
6,250
-89,262
-93% -$8.28K ﹤0.01% 305
2024
Q4
$10.5K Hold
95,512
﹤0.01% 256
2024
Q3
$3.84K Hold
95,512
﹤0.01% 261
2024
Q2
$6.21K Hold
95,512
﹤0.01% 210
2024
Q1
$4.3K Hold
95,512
﹤0.01% 218
2023
Q4
$2.87K Hold
95,512
﹤0.01% 241
2023
Q3
$6.69K Hold
95,512
﹤0.01% 269
2023
Q2
$9.55K Hold
95,512
﹤0.01% 288
2023
Q1
$9.55K Hold
95,512
﹤0.01% 341
2022
Q4
$38.2K Buy
+95,512
New +$41.8K ﹤0.01% 274

Altshuler Shaham's CTV.WS Position: Q2 2025 in Review

Altshuler Shaham sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q2 2025, closing a stake of 6,250 shares — an estimated $625 sold.

Altshuler Shaham first reported a position in CTV.WS in Q4 2022 and held it in 10 quarters. The position peaked at $38.2K in Q4 2022. 0 funds tracked by Wall St. Rank hold CTV.WS as of Q2 2025.

  • Altshuler Shaham reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2025 after selling out during the quarter.
  • Altshuler Shaham sold 6,250 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2025, an estimated $625.
  • Altshuler Shaham first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2022 and held it in 10 quarters.
  • Altshuler Shaham's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $38.2K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2025.

Based on Altshuler Shaham's 13F filing for Q2 2025, filed 14 Aug 2025.